Drug of choice in cardiogenic shock is
**Core Concept**
Cardiogenic shock is a life-threatening condition characterized by the heart's inability to pump enough blood to meet the body's needs, resulting from a variety of causes such as myocardial infarction, cardiac tamponade, or severe heart failure. The treatment of choice aims to restore cardiac output, improve perfusion, and stabilize the patient.
**Why the Correct Answer is Right**
The drug of choice in cardiogenic shock is dobutamine, a beta-adrenergic agonist that increases contractility and heart rate, thereby improving cardiac output. Dobutamine works by stimulating beta-1 receptors in the heart, leading to an increase in cyclic AMP (cAMP) levels, which ultimately enhances myocardial contractility. This effect is particularly beneficial in patients with cardiogenic shock, as it helps to improve cardiac function and increase blood pressure.
**Why Each Wrong Option is Incorrect**
**Option A:** Norepinephrine is a potent vasoconstrictor used in septic shock to increase blood pressure, but it is not the first-line treatment for cardiogenic shock.
**Option B:** Milrinone is a phosphodiesterase inhibitor that increases cAMP levels, but it is typically used in combination with dobutamine in cardiogenic shock.
**Option C:** Epinephrine is a non-selective adrenergic agonist that can be used in cardiogenic shock, but dobutamine is generally preferred due to its more targeted effects on the heart.
**Clinical Pearl / High-Yield Fact**
In cardiogenic shock, the use of vasopressors like norepinephrine can lead to a decrease in cardiac output due to increased afterload, making dobutamine a more suitable choice to improve cardiac function.
**Correct Answer:** C. Dobutamine.